HomePHIO • NASDAQ
add
Phio Pharmaceuticals Corp
Previous close
$0.83
Day range
$0.66 - $0.83
Year range
$0.50 - $6.85
Market cap
3.33M USD
Avg Volume
430.67K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 688.00K | -38.35% |
Net income | -1.90M | 30.61% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.68M | 37.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.49M | -27.93% |
Total assets | 9.36M | -26.92% |
Total liabilities | 1.63M | -17.22% |
Total equity | 7.73M | — |
Shares outstanding | 4.59M | — |
Price to book | 0.40 | — |
Return on assets | -44.83% | — |
Return on capital | -56.32% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.90M | 30.61% |
Cash from operations | -2.37M | 12.38% |
Cash from investing | 0.00 | — |
Cash from financing | 2.40M | 120,050.00% |
Net change in cash | 33.00K | 101.22% |
Free cash flow | -1.58M | 4.42% |
About
Phio Pharmaceuticals Inc. is a US biotechnology company focused on the field of siRNA. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Founded
2011
Headquarters
Website
Employees
9